ClinicalTrials.gov
ClinicalTrials.gov Menu

Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01208480
Recruitment Status : Completed
First Posted : September 24, 2010
Last Update Posted : April 10, 2012
Sponsor:
Information provided by (Responsible Party):
Joohyuk Sohn, Severance Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2012
  Actual Study Completion Date : February 2012